Research & Development

图片偷拍网超碰在线免费公开视频超碰免费视频在线观看药品上市许可持有人数据库上线 公众可官网检索


  黎江怔愣了一下,“啊?哦,也沒想什麼,就……想起江彭亮了。”   她給黎舟收拾了一個房間,坐在那多陪了黎舟一會,怕剛才陸老大那一通胡鬧嚇著孩子。图片偷拍网   徒弟樂了︰“沒什麼,小師弟夸您教的好呢,玩兒著學都能學會!”超碰在线免费公开视频   “除了媽媽和外公,其他人說的話,你都要多想想再信。”   那是他第一次受傷,現在想起來的時候手腕上還隱隱發寒,那把刀再進的深一些,手筋都要被挑斷。超碰免费视频在线观看   但是他們身體一動,小皮立刻就發現了,在籠子里急的不行,儼然有撞籠的架勢。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo